Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02369029
Title BAY1238097, First in Man
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | FRA | FIN | DEU | CHE


No variant requirements are available.